APA

Knyazev E. N., Fomicheva K. A., Mikhailenko D. S., Nyushko K. M., Samatov T. R., Alekseev B. Y. & Shkurnikov M. Y. (20170213). Plasma Levels of hsa-miR-619-5p and hsa-miR-1184 Differ in Prostatic Benign Hyperplasia and Cancer. : Bulletin of experimental biology and medicine.

Chicago

Knyazev E N, Fomicheva K A, Mikhailenko D S, Nyushko K M, Samatov T R, Alekseev B Ya and Shkurnikov M Yu. 20170213. Plasma Levels of hsa-miR-619-5p and hsa-miR-1184 Differ in Prostatic Benign Hyperplasia and Cancer. : Bulletin of experimental biology and medicine.

Harvard

Knyazev E. N., Fomicheva K. A., Mikhailenko D. S., Nyushko K. M., Samatov T. R., Alekseev B. Y. and Shkurnikov M. Y. (20170213). Plasma Levels of hsa-miR-619-5p and hsa-miR-1184 Differ in Prostatic Benign Hyperplasia and Cancer. : Bulletin of experimental biology and medicine.

MLA

Knyazev E N, Fomicheva K A, Mikhailenko D S, Nyushko K M, Samatov T R, Alekseev B Ya and Shkurnikov M Yu. Plasma Levels of hsa-miR-619-5p and hsa-miR-1184 Differ in Prostatic Benign Hyperplasia and Cancer. : Bulletin of experimental biology and medicine. 20170213.